Rex Cancer Center UNC Healthcare — Raleigh, North Carolina

Rex Cancer Center UNC Healthcare is a clinical research site located in Raleigh, North Carolina, United States 27607.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Rex Cancer Center UNC Healthcare has participated in 1 clinical trials.

Therapeutic areas: Metastatic Pancreatic Adenocarcinoma.

Sponsors: Traws Pharma, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Rex Cancer Center UNC Healthcare?

Rex Cancer Center UNC Healthcare has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Rex Cancer Center UNC Healthcare conducted?

Rex Cancer Center UNC Healthcare has 1 clinical trials on record. Their work covers Metastatic Pancreatic Adenocarcinoma.

Is Rex Cancer Center UNC Healthcare accredited by Crixeo Health?

Rex Cancer Center UNC Healthcare has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Rex Cancer Center UNC Healthcare?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.